BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3

• Press Releases

  Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

  October 2, 2025

   · 

  3 min read
• Press Releases

  Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer

  October 2, 2025

   · 

  3 min read
• Press Releases

  Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility

  October 2, 2025

   · 

  4 min read
• Press Releases

  AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage

  October 2, 2025

   · 

  5 min read
• Press Releases

  IRLAB Progresses Fully Funded IRL757 Study in Parkinson’s Disease in Partnership with MSRD

  October 2, 2025

   · 

  4 min read
• Press Releases

  Newron to Present New Analyses From and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 38th European College of Neuropsychopharmacology (ECNP) Congress 2025

  October 2, 2025

   · 

  8 min read
• Press Releases

  Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars

  October 2, 2025

   · 

  13 min read
• Press Releases

  EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients

  October 2, 2025

   · 

  5 min read
• Press Releases

  KalVista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors

  October 2, 2025

   · 

  4 min read
• Press Releases

  Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156

  October 2, 2025

   · 

  3 min read